Skip to main content

Publications

Found 30 results
[ Author(Asc)] Title Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Myers J, Myatt L, Roberts J, Redman C. COLLECT, a collaborative database for pregnancy and placental research studies worldwide. BJOG. 2019;126(1):8-10.  (127.54 KB)
Myers J. What are the metabolic precursors which increase the risk of pre-eclampsia and how could these be investigated further. Placenta. 2017;60:110-114.  (491.22 KB)
Myatt L, Roberts J, Redman C. Availability of COLLECT, a database for pregnancy and placental research studies worldwide. Placenta. 2017;57:223-224.  (141.67 KB)
Myatt L, Redman C, Staff A, Hansson S, Wilson M, Laivuori H, et al.. Strategy for standardization of preeclampsia research study design. Hypertension. 2014;63(6):1293-301.  (1.19 MB)
Munguambe K, Boene H, Vidler M, Bique C, Sawchuck D, Firoz T, et al.. Barriers and facilitators to health care seeking behaviours in pregnancy in rural communities of southern Mozambique. Reprod Health. 2016;13 Suppl 1:31.  (1.03 MB)
Molla Y, Rawlins B, Makanga P, Cunningham M, Ávila JEugenio He, Ruktanonchai C, et al.. Geographic information system for improving maternal and newborn health: recommendations for policy and programs. BMC Pregnancy Childbirth. 2017;17(1):26.  (3.02 MB)
Mol B, Roberts C, Thangaratinam S, Magee LA, de Groot C, Hofmeyr J. Pre-eclampsia. Lancet. 2016;387(10022):999-1011.  (128.83 KB)
Millman A, Payne BA, Qu Z, M Douglas J, Hutcheon J, Lee T, et al.. Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can. 2011;33(7):705-714.  (383.37 KB)
Mateus J, Newman R, Sibai B, Li Q, Barton J, C Combs A, et al.. Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in Preeclampsia. AJP Rep. 2017;7(1):e49-e58.  (184.83 KB)
Marianne V. Community perceptions of the hypertensive disorders of pregnancy. In 2017.  (2.63 MB)
Makanga P, Schuurman N, Sacoor C, Boene H, Vilanculo F, Vidler M, et al.. Seasonal variation in geographical access to maternal health services in regions of southern Mozambique. Int J Health Geogr. 2017;16(1):1.  (9.27 MB)
Makanga P, Schuurman N, Sacoor C, Boene H, von Dadelszen P, Firoz T. Guidelines for creating framework data for GIS analysis in low- and middle-income countries. The Canadian Geographer / Le Géographe canadien. 2016;60(3):320 - 332.  (5.32 MB)
Makanga P, Schuurman N, von Dadelszen P, Firoz T. A scoping review of geographic information systems in maternal health. Int J Gynaecol Obstet. 2016;134(1):13-7.  (497.99 KB)
Makanga P, Sacoor C, Schuurman N, Lee T, Vilanculo F, Munguambe K, et al.. Place-specific factors associated with adverse maternal and perinatal outcomes in Southern Mozambique: a retrospective cohort study. BMJ Open. 2019;9(2):e024042.  (2.94 MB)
Magee LA, Sawchuck D, Synnes A, von Dadelszen P, Basso M, Crane J, et al.. Magnesium Sulphate for Fetal Neuroprotection. Journal of Obstetrics and Gynaecology Canada. 2011;33(5):516 - 529.  (298.54 KB)
Magee LA, Namouz-Haddad S, Cao V, Koren G, von Dadelszen P. Labetalol for hypertension in pregnancy. Expert Opin Drug Saf. 2015;14(3):453-61.  (463.16 KB)
Magee LA, Helewa M, Rey E. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008;30(3 Suppl):S1-S2.  (1.73 MB)
Magee LA, von Dadelszen P. Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev. 2013;(4):CD004351.  (447.63 KB)
Magee LA, Lowe S, M Douglas J, Kathirgamanathan A. Therapeutics and anaesthesia. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):477-90.  (187.9 KB)
Magee LA, Côté A-M, Joseph G, Firoz T, Sia W. Obstetric medical care in Canada. Obstet Med. 2016;9(3):117-9.  (81.97 KB)
Magee LA, Synnes A, von Dadelszen P, Hutfield A, Chanoine J-P, Côté A-M, et al.. CHIPS-Child: Testing the developmental programming hypothesis in the offspring of the CHIPS trial. Pregnancy Hypertens. 2018;14:15-22.  (1011.52 KB)
Magee LA, Sharma S, Nathan H, Adetoro OO, Bellad MB, Goudar S, et al.. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis. PLoS Med. 2019;16(4):e1002783.  (864.32 KB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?. Hypertension. 2016;68(5):1153-1159.  (476.19 KB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial. Acta Obstet Gynecol Scand. 2016;95(7):763-76.  (803.67 KB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?. BJOG. 2016;123(7):1135-41.  (144.71 KB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG. 2016;123(7):1143-51.  (153.93 KB)
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. The hypertensive disorders of pregnancy (29.3). Best Pract Res Clin Obstet Gynaecol. 2015;29(5):643-57.  (227.04 KB)
Magee LA, Singer J, von Dadelszen P. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(24):2367-8.  (515.75 KB)
Magee LA, von Dadelszen P, Asztalos E, Ross S, Rey E. 34 weeks of gestation-lost in translation. J Obstet Gynaecol Can. 2014;36(6):480-481.  (706.24 KB)
Magee LA, von Dadelszen P, Allen V, Ansermino JM, Audibert F, Barrett J, et al.. The Canadian Perinatal Network: a national network focused on threatened preterm birth at 22 to 28 weeks' gestation. J Obstet Gynaecol Can. 2011;33(2):111-120.  (322.85 KB)